UTI-Healthcare Fund – Direct Growth

Equity . Sectoral / Thematic
Monthly Amount Invested
Duration
Yr
  • Would Have Become
    --
  • Invested Value
    --
  • Total Gain
    --
  • Returns
    -- per annum
₹ 500 ₹ 5,000 1.18 % 0★ ₹ - 9 Years
Min SIP Min Lumpsum Expense Ratio Rating Fund Size Fund Age
₹ 500 ₹ 5,000 1.18 %
Min SIP Min Lumpsum Expense Ratio
0★ ₹ 1.18 Cr 9 Years
Rating Fund Size Fund Age

Scheme Performance

Returns and Ranks ( as on April 28.2022 )
1 Month1M 1 Year1Y 3 Years3Y 5 Years5Y
Trailing Returns -11.87% 22.27% 12.28% 13.11%
Category Average -14.29% -13.79% 9.94% -

Scheme Allocation

Holding
Sector
Asset
Sun Pharma.Inds.
11.06%
Dr Reddy's Labs
9.17%
Cipla
8.61%
Fortis Health.
4.7%
Aurobindo Pharma
4.43%
Others
62.03%
Healthcare Services
16.74%
Cash & Others
1.18%
Others
0.3%
Debt
0.19%
Others
81.59%
Equity
98.35%
Net Curr Ass/Net Receivables
1.18%
Fixed Deposit
0.3%
T-Bills
0.19%

Exit Load & Tax Implication

Exit Load 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment.

Advance Ratio

-0.06 0.95 0.58 -0.05
Alpha SD Beta Sharpe

Risk-O-Meter

AMC Contact Details

UTI Mutual Fund
AUM:
2,23,842 Cr
Address:
UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051
Contact:
66786666
Email ID:
service@uti.co.in

Frequently Asked Questions

The NAV of UTI-Healthcare Fund – Direct Growth is ₹153.29 as of 28 June 2022.